Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread. While virus numbers are not high right now in ...

It would be unhealthy to let Robert F. Kennedy Jr. take ... expected sales of its COVID-19 vaccine, even with low revenue from its new respiratory syncytial virus shot. Volunteer veterinarians ...

Previously, the adjuvanted RSV prefusion F protein-based vaccine had been approved only for adults ages 60 and older. Then in October, the FDA expanded the approval of Pfizer's bivalent RSV ...

A lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your ... 2 while the Novavax vaccine targets its parent strain, JN.1. Daskalakis said all ...

Go to source) for newborns and pregnant women. Mark Butler, the minister for health, announced 174.5 million Australian dollars ($114.8 million) in funding to subsidize RSV vaccinations following ...

Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized mRNA ...

TORONTO — Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, the company ...

WAUSAU, Wis. (WSAW) --- Doctors recommend that people learn about the RSV vaccine as cold and flu season approaches Wisconsin. RSV, or Respiratory Syncytial Virus, is a common contagious virus ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus, or RSV, in adults 60 years and older, making it the country's first authorized mRNA-based ...

mRESVIA is an RSV vaccine that consists of an mRNA sequence encoding RSV glycoprotein F stabilized in the prefusion conformation. The F glycoprotein is expressed on the surface of the virus and is ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA ...